WASHINGTON, Dec. 21, 2020 /PRNewswire/ -- Danaher
Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC")
Gutierrez-Ramos has been named Senior Vice President and Chief
Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos
will have responsibility for helping define Danaher's science and
technology strategy across the organization, including facilitating
innovation and further development of scientific and technology
talent. With this appointment, Dr. Gutierrez-Ramos will become an
executive officer of the Company and report directly to
Rainer M. Blair, President and Chief
Executive Officer.
Mr. Blair stated, "JC brings tremendous scientific and
technological expertise to Danaher. The depth of his experience
combined with his innovation leadership will be important
contributions as we continue to build a stronger, better Danaher.
We are excited to welcome JC to the Danaher team."
Dr. Gutierrez-Ramos joins Danaher from Abbvie where he served as
the Head of Global Drug Discovery and was a member of the executive
R&D team. Prior to Abbvie, Dr. Gutierrez-Ramos was President
and CEO of Repertoire Immune Medicines and Synlogic, and he
previously served in a series of progressively more responsible
R&D roles at Pfizer Inc., GlaxoSmithKline PLC, Avidia (Amgen
Inc.) and Millennium Pharmaceuticals, Inc.
Prior to working in the private sector, Dr. Gutierrez-Ramos was
a tenure track professor at Harvard Medical
School in the Department of Genetics and an Investigator at
The Center for Blood Research. He was also a professor for
the Spanish Scientific Research Council (CSIC) at the National
Center of Biotechnology in Madrid,
Spain. He was a scientist and member at the prestigious
Basel Institute for Immunology in Basel,
Switzerland and a Postdoctoral Fellow at the Max Plank
Institute for Immunbiologie in Freiburg, Germany.
Dr. Gutierrez-Ramos earned a Ph.D from the Immunology Department
of the Center for Molecular Biology at the Universidad Autonoma de
Madrid, Spain and a Bachelor of
Science degree, summa cum laude, in Chemistry with a minor in
Biochemistry from the Universidad Complutense de Madrid, Spain.
ABOUT DANAHER
Danaher is a global science and
technology innovator committed to helping its customers solve
complex challenges and improving quality of life around the world.
Its family of world class brands has leadership positions in the
demanding and attractive health care, environmental and applied
end-markets. With more than 20 operating companies, Danaher's
globally diverse team of more than 67,000 associates is united by a
common culture and operating system, the Danaher Business System,
and its Shared Purpose, Helping Realize Life's Potential.
For more information, please visit www.danaher.com.
View original
content:http://www.prnewswire.com/news-releases/danaher-announces-executive-appointment-301197027.html
SOURCE Danaher Corporation